A. Shabbir, L. Yumn, and E. Khan, “Mavacamten’s therapeutic impact: cardiac-specific myosin inhibition in obstructive hypertrophic cardiomyopathy”, Global Cardiol, vol. 2, no. 3, Nov. 2024.